These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31735308)

  • 21. Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure: A Meta-Analysis.
    Savarese G; Giugliano RP; Rosano GM; McMurray J; Magnani G; Filippatos G; Dellegrottaglie S; Lund LH; Trimarco B; Perrone-Filardi P
    JACC Heart Fail; 2016 Nov; 4(11):870-880. PubMed ID: 27614940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Singer DE; Albers GW; Dalen JE; Fang MC; Go AS; Halperin JL; Lip GYH; Manning WJ
    Chest; 2008 Jun; 133(6 Suppl):546S-592S. PubMed ID: 18574273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial fibrillation: stroke prevention in older adults.
    Quinn GR; Fang MC
    Clin Geriatr Med; 2012 Nov; 28(4):617-34. PubMed ID: 23101573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
    Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
    Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral anticoagulation in patients with cardiomyopathy or heart failure in sinus rhythm.
    Pullicino P; Thompson JL; Mohr JP; Sacco RL; Freudenberger R; Levin B; Homma S
    Cerebrovasc Dis; 2008; 26(3):322-7. PubMed ID: 18667814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct oral anticoagulants across the heart failure spectrum: the precision medicine era.
    Paolillo S; Ruocco G; Filardi PP; Palazzuoli A; Tocchetti CG; Nodari S; Lombardi C; Metra M; Correale M;
    Heart Fail Rev; 2022 Jan; 27(1):135-145. PubMed ID: 32583229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now?
    Dzeshka MS; Lip GY
    Trends Cardiovasc Med; 2015 May; 25(4):315-36. PubMed ID: 25440108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of oral antithrombotic treatment in elderly patients with atrial fibrillation.
    Kato ET; Goto S; Giugliano RP
    Ageing Res Rev; 2019 Jan; 49():115-124. PubMed ID: 30359765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stroke Prevention in Atrial Fibrillation: The Role of Oral Anticoagulation.
    Mtwesi V; Amit G
    Med Clin North Am; 2019 Sep; 103(5):847-862. PubMed ID: 31378330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group.
    Pharithi RB; Ranganathan D; O'Brien J; Egom EE; Burke C; Ryan D; McAuliffe C; Vaughan M; Coughlan T; Morrissey E; McHugh J; Moore D; Collins R
    Ir J Med Sci; 2019 Feb; 188(1):101-108. PubMed ID: 29860595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-vitamin K antagonist oral anticoagulants and heart failure.
    Isnard R; Bauer F; Cohen-Solal A; Damy T; Donal E; Galinier M; Hagège A; Jourdain P; Leclercq C; Sabatier R; Trochu JN; Cohen A
    Arch Cardiovasc Dis; 2016 Nov; 109(11):641-650. PubMed ID: 27836786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical relevance of pharmacokinetic and pharmacodynamic properties of edoxaban when treating patients with atrial fibrillation and heart failure.
    Aspromonte N; Colivicchi F
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):113-122. PubMed ID: 27819149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic therapy for stroke prevention in patients with atrial fibrillation in Japan.
    Maruhashi T; Higashi Y
    Expert Opin Pharmacother; 2020 Dec; 21(17):2115-2124. PubMed ID: 32749891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.
    van Nieuwenhuizen KM; van der Worp HB; Algra A; Kappelle LJ; Rinkel GJ; van Gelder IC; Schutgens RE; Klijn CJ;
    Trials; 2015 Sep; 16():393. PubMed ID: 26340977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulation for heart failure: selecting the best therapy.
    Kohsaka S; Homma S
    Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1209-17. PubMed ID: 19814664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Challenges of long-term anticoagulation in women: is heart failure relevant?].
    Undas A
    Przegl Lek; 2016; 73(6):430-4. PubMed ID: 29671307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Thrombotic risk factors and antithrombotic treatment in atrial fibrillation].
    Bounhoure JP
    Bull Acad Natl Med; 2011; 195(4-5):963-74; discussion 974-7. PubMed ID: 22375363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stroke prevention in atrial fibrillation: current anticoagulation management and future directions.
    Fitzgerald BT; Cohn SL; Klein AL
    Cleve Clin J Med; 2005 Apr; 72 Suppl 1():S24-30. PubMed ID: 15853176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence.
    Ferguson C; Inglis SC; Newton PJ; Middleton S; Macdonald PS; Davidson PM
    Vasc Health Risk Manag; 2013; 9():3-11. PubMed ID: 23345982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.